| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63522d9e03b082b91496ce608c0bed1b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate |
2015-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b31a53711fd99213e72ec8d4fc680643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8c35ba671b19285e400b1177f8036d |
| publicationDate |
2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9855249-B2 |
| titleOfInvention |
Isoxazole compounds and methods for the treatment of cystic fibrosis |
| abstract |
The invention relates to a compound of Formula I and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or II to a patient in need thereof: |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11247986-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10774054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10329286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10220027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10421730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11225473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524005-B2 |
| priorityDate |
2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |